Investigation Report on China Cilostazol Market, 2010-2019

Publisher Name :
Date: 18-Aug-2015
No. of pages: 30

Cilostazol is a medication used in the alleviation of chronic ulcer, pain, chills and intermittent claudication caused by limb ischemia. It is also frequently used to alleviate symptoms, improve circulation and inhibit thrombus in the postoperative treatment of angioplasty, vascular graft and sympathectomy. As a nation with the largest population in the world, China reports a huge demand for medicines. Currently, as population structure changes and environmental problems spring up, Chinese people's health suffers from great harm. Cilostazol with its medicinal properties will enjoy a large market and play an important role in future.

Cilostazol develops fast after entering China, annual sales rising from CNY 35.95 million in 2010 to CNY 66.91 million in 2014 and CAGR during this period reaching 16.80%. Cilostazol enjoys a vast demand in China. Otsuka Co., Ltd, Zhejiang Weikang Pharmaceutical Co., Ltd, Chengdu Leer Pharmaceutical Co., Ltd, Pharsin and Yantai Yisheng Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which Otsuka Co., Ltd had the largest market share of about 63.62% with sales value reaching up to CNY 42.57 million in 2014.

Readers can get at least the following information through this report:


  • market size of cilostazol in China

  • competitive landscape of cilostazol market in China

  • price of cilostazol made by different enterprises in China

  • market outlook of cilostazol in China


The author suggests the following groups of people purchase this report:


  • investors/research institutions interested in Chinese medicine market

  • any interest in Chinese medicine market, please contact CRI for customized survey service


Companies Mentioned

Zhejiang Otsuka Pharmaceutical Co.,Ltd.; Zhejiang Weikang Pharmaceutical Co., Ltd; Chongqing Pharscin pharmaceutical Co. Ltd.; Chengdu Leer Pharmaceutical Co., Ltd; Yantai Yisheng Pharmaceutical Co., Ltd

Investigation Report on China Cilostazol Market, 2010-2019

Table of Contents

1 Related Concepts of Cilostazol
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Cilostazol in China
2.1 Patent and Approval Information of Cilostazol in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Cilostazol Sales in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Cilostazol Manufacturers in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Cilostazol in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Cilostazol in Chinese Hospitals in 2014
6.1 Zhejiang Otsuka Co., Ltd
6.2 Zhejiang Weikang Pharmaceutical Co., Ltd
6.3 Chongqing Pharscin pharmaceutical Co. Ltd.
6.4 Chengdu Leer Pharmaceutical Co., Ltd
6.5 Yantai Yisheng Pharmaceutical Co., Ltd

7 Major Manufacturers of Cilostazol in Chinese Market, 2010-2014
7.1 Zhejiang Otsuka Pharmaceutical Co.,Ltd.
7.2 Zhejiang Weikang Pharmaceutical Co., Ltd
7.3 Chongqing Pharscin pharmaceutical Co. Ltd.
7.4 Chengdu Leer Pharmaceutical Co., Ltd
7.5 Yantai Yisheng Pharmaceutical Co., Ltd

8 Market Outlook of Cilostazol in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

List of Charts

Chart Approval Information of Cilostazol in China
Chart Sales Status of Cilostazol in China
Chart Sales Value of Cilostazol in China, 2010-2014
Chart Sales Value of Cilostazol in Some Regions in China, 2010-2014
Chart Sales Volume of Cilostazol in China, 2010-2014
Chart Sales Volume of Cilostazol in Some Regions in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Cilostazol for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Cilostazol Made by Zhejiang Otsuka in China, 2010-2014
Chart Sales Value and Market Share of Cilostazol Made by Zhejiang Weikang in China, 2010-2014
Chart Sales Value and Market Share of Cilostazol Made by Chengdu Leer in China, 2010-2014
Chart Sales Value and Market Share of Cilostazol Made by Chongqing Pharsin in China, 2010-2014
Chart Sales Value and Market Share of Cilostazol Made by Yantai Yisheng in China, 2010-2014
Chart Sales Value and Market Share of Cilostazol Capsule in China, 2010-2014
Chart Sales Value and Market Share of Cilostazol Tablet in China, 2010-2014
Chart Price of Cilostazol Made by Otsuka in Some Chinese Cities in 2014
Chart Price of Cilostazol Made by Zhejiang Weikang in Some Chinese Cities in 2014
Chart Price of Cilostazol Made by Pharsin in Some Chinese Cities in 2014
Chart Price of Cilostazol Made by Chengdu Leer in Some Chinese Cities in 2014
Chart Price of Cilostazol Made by Yantai Yisheng in Some Chinese Cities in 2014

  • Global Digoxin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 75
    According to our LPI (LP Information) latest study, the global Digoxin market size was valued at US$ 59 million in 2023. With growing demand in downstream market, the Digoxin is forecast to a readjusted size of US$ 73 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Digoxin market. Digoxin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain op......
  • Global Heart Failure Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Heart Failure Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Heart Failure Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Heart Failure Drugs market. Heart Failure Drugs are expected to show stable growth in the future market. However, product differentiatio......
  • Global Atorvastatin Calcium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138
    According to our LPI (LP Information) latest study, the global Atorvastatin Calcium market size was valued at US$ 214.2 million in 2023. With growing demand in downstream market, the Atorvastatin Calcium is forecast to a readjusted size of US$ 362 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Atorvastatin Calcium market. Atorvastatin Calcium are expected to show stable growth in the future market. However, prod......
  • Global Rosuvastatin Calcium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139
    According to our LPI (LP Information) latest study, the global Rosuvastatin Calcium market size was valued at US$ 514.3 million in 2023. With growing demand in downstream market, the Rosuvastatin Calcium is forecast to a readjusted size of US$ 683.6 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Rosuvastatin Calcium market. Rosuvastatin Calcium are expected to show stable growth in the future market. However, pr......
  • Global Atorvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 133
    According to our (Global Info Research) latest study, the global Atorvastatin Calcium market size was valued at USD 225.3 million in 2023 and is forecast to a readjusted size of USD 366.1 million by 2030 with a CAGR of 7.2% during review period. Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL choleste......
  • Global Rosuvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132
    According to our (Global Info Research) latest study, the global Rosuvastatin Calcium market size was valued at USD 540.9 million in 2023 and is forecast to a readjusted size of USD 703.6 million by 2030 with a CAGR of 3.8% during review period. Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart att......
  • Cilostazol - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118
    The global Cilostazol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cilostazol in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Cilostazol market. Injection Cilostazol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-dried P......
  • Rosuvastatin - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 110
    Rosuvastatin medication is a statin that is used to lower bad cholesterol and prevent cardiovascular disease. It works by blocking an enzyme in the liver that makes cholesterol. It is taken by mouth and should be used together with dietary changes, exercise, and weight loss. It may also raise good cholesterol and lower triglycerides. It is sold under the brand name Crestor among others. It may be used when other statins have not worked well. The global Rosuvastatin market size is expected......
  • Global Congestive Heart Failure Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Congestive Heart Failure Drugs market: According to our latest research, the global Congestive Heart Failure Drugs market looks promising in the next 5 years. As of 2022, the global Congestive Heart Failure Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Congestive heart failure is a serious and complex condition in which the heart muscles are either dam......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs